Actelion is a global, independent biopharmaceutical company discovering, developing and marketing innovative drugs for high unmet medical needs.

Amicus Therapeutics is pioneering a paradigm-shifting approach to treating a range of human genetic diseases in which crucial proteins are misfolded, thus reducing or eliminating their functionality. Amicus develops pharmacological chaperones - oral therapies that bind to and stabilize the affected proteins, restoring their shape, proper trafficking, and biological activity. This novel, next-generation approach offers the potential to improve treatment options for patients with genetic diseases.

Genzyme is one of the world’s leading biotechnology companies. Its more than 10,000 employees work in countries throughout the world and are united by a common goal: to make a major positive impact on the lives of people with debilitating diseases. Look also into their info link.

IISC is a non-profit organisation that
partners with individuals, organizations
and communities to achieve greater
social impact. It does this through providing training, facilitation and coaching services to the public and not-for-profit sectors.

Sanders & Clients BV
is a Dutch company that deliver equipment to infuse the medicine.

Shire is a global company with offices in the major pharmaceutical markets. Its world headquarters are in Basingstoke, UK and its US headquarters in Wayne, Pennsylvania. Look also into their info link.